» Articles » PMID: 10506298

Health Care Utilization and Costs Among Patients Treated for Bipolar Disorder in an Insured Population

Overview
Journal Psychiatr Serv
Specialty Psychiatry
Date 1999 Oct 3
PMID 10506298
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The study examined health care utilization and costs among patients treated for bipolar-spectrum disorders in an insured population.

Methods: Computerized data on prescriptions and on outpatient and inpatient diagnoses from a large health plan were used to identify patients treated for cyclothymia, bipolar disorder, or schizoaffective disorder. Three age- and sex-matched comparison groups consisting of general medical outpatients, patients treated for depression, and patients treated for diabetes were selected from health plan members. Utilization and cost of health services for the four groups over a six-month period were assessed using computerized accounting records.

Results: Total mean+/-SD costs for patients in the bipolar disorder group ($3,416+/-$6,862) were significantly higher than those in any of the comparison groups. Specialty mental health and substance abuse services accounted for 45 percent of total costs in the group with bipolar disorder (mean+/-SD=$1, 566+/-$3,243), compared with 10 percent in the group with depression. Among patients treated for bipolar disorder, 5 percent of patients accounted for approximately 40 percent of costs for specialty mental health and substance abuse services, 90 percent of inpatient costs for specialty mental health and substance abuse services, and 95 percent of out-of-pocket costs for inpatient care. In the bipolar disorder group, parity coverage of inpatient mental health and substance abuse services would increase overall health care costs by 6 percent.

Conclusions: Health care costs for patients with bipolar disorder exceed those for patients treated for depression or diabetes, and specialty mental health and substance abuse treatment costs account for this difference. Costs to the insurer and costs borne by patients are accounted for by a small proportion of patients. Elimination of discriminatory mental health coverage would have a small effect on overall health care costs.

Citing Articles

A Qualitative Study Exploring Access to Mental Health and Substance Use Support among Individuals Experiencing Homelessness during COVID-19.

Adams E, Parker J, Jablonski T, Kennedy J, Tasker F, Hunter D Int J Environ Res Public Health. 2022; 19(6).

PMID: 35329147 PMC: 8950841. DOI: 10.3390/ijerph19063459.


Prediction of risk of prolonged post-concussion symptoms: Derivation and validation of the TRICORDRR (Toronto Rehabilitation Institute Concussion Outcome Determination and Rehab Recommendations) score.

Langer L, Alavinia S, Lawrence D, Munce S, Kam A, Tam A PLoS Med. 2021; 18(7):e1003652.

PMID: 34237056 PMC: 8266123. DOI: 10.1371/journal.pmed.1003652.


Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia.

Caroff S, Mu F, Ayyagari R, Schilling T, Abler V, Carroll B BMC Psychiatry. 2020; 20(1):365.

PMID: 32652964 PMC: 7353680. DOI: 10.1186/s12888-020-02748-0.


Treatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders: An Integrative Literature Review.

Priester M, Browne T, Iachini A, Clone S, DeHart D, Seay K J Subst Abuse Treat. 2015; 61:47-59.

PMID: 26531892 PMC: 4695242. DOI: 10.1016/j.jsat.2015.09.006.


State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder.

Brown J, Barrett A, Hourihan K, Caffery E, Ireys H Community Ment Health J. 2015; 51(5):523-34.

PMID: 25786723 DOI: 10.1007/s10597-015-9857-5.